Devices and procedures for mounting a therapeutic device such as a microactuator of a implantable hearing aid system into a fenestration through the otic capsule bone, e.g. the lateral wall of the cochlea, to communicate with fluid within the inner ear.
The hearing portion of the inner ear is enclosed within a hollow, spiral otic capsule bone shaped like a snail shell that is also referred to as the cochlea. The cochlea is a fluid-filled portion of the inner ear that contains nerve endings essential for hearing.
A biologically sealed attachment into the otic capsule bone that is stable and watertight is often desired for various medical devices and therapies. U.S. Pat. No. 5,951,601 (“the '601 patent”) and published United States Published Patent Application No. 2005/02033557 A1 (“the U.S. patent application”) both respectively describe procedures for attaching a therapeutic device, such as a microactuator, in a fenestration which pierces the otic capsule bone.
The inventions disclosed in the '601 patent and the U.S. patent application exhibit several advantages. A casing locates a therapeutic device very securely, without vibration. In addition, those inventions facilitate removing a therapeutic device if that were to become necessary. Thirdly, together with a precise atraumatic fenestration procedure the casing provides for a very precise location for a therapeutic device such as a microactuator. Thus, the casing ensures a microactuator or other therapeutic device is optimally situated in the cochlea without damaging the delicate structures of the inner ear.
The casings respectively disclosed in the '601 patent and the U.S. patent application are particularly adapted for implantation into a fenestration that pierces a projecting portion of the otic capsule bone called the promontory. As described in the '601 patent and the U.S. patent application, the casings are adapted for receiving and attaching to a subject a microactuator included in the implantable hearing aid system, a dummy plug to replace the microactuator should its removal become necessary, or any other type of therapeutic device that interacts with fluid or structures within the cochlea. If the casing receives a microactuator, applying an electric signal thereto causes the microactuator to directly stimulate fluid within the inner ear, which stimulation the subject perceives as sound.
A casing for attaching a therapeutic device to a fenestration formed through a subject's promontory in accordance with the respective disclosures of the '601 patent and of the U.S. patent application includes a sleeve having an outer surface. During implantation of the casing, a first end of the sleeve is received into the fenestration. Disposed in that location, the outer surface of the sleeve mates with the fenestration for securing the casing within the fenestration. The hollow sleeve includes an inner surface adapted to receive a barrel of the microactuator.
The casing also includes a flange that is integral with the sleeve. The flange projects outward from the outer surface of the sleeve about a second end of the sleeve that is located distal from the first end. The flange, through contact with the promontory, limits a depth to which the first end of the sleeve may enter into the fenestration.
A casing in accordance with the '601 patent or with the U.S. patent application may employ various means for securing the sleeve within the fenestration such as screwing into the promontory or clamping to the promontory. Similarly, such a casing may fasten the microactuator to the casing in various ways such as by a threaded attachment, with screws, with button-and-socket snap fasteners, or with a slotted tongue-and-groove lock. A casing in accordance with the '601 patent or the U.S. patent application may also include a keyway that receives a mating key formed on the barrel of the microactuator for establishing an orientation of the implanted microactuator.
One difficulty in a procedure for securing a therapeutic appliance into the otic capsule bone is that the attachment be biologically sealed. Another difficulty in a process for securing a biologically sealed therapeutic appliance to the cochlea is safely fenestrating the otic capsule bone, particularly the tiny promontory. For example, the maximum diameter of a fenestration piercing the otic capsule bone is approximately 1.0 to 1.5 mm. Furthermore, fenestrating the otic capsule bone must be accomplished without damaging the membranous labyrinth or organ of corti enclosed within the otic capsule bone, i.e. without damaging hearing.
An object is to facilitate attachment of a therapeutic appliance, such as a microactuator or micropump for delivering a drug or therapeutic agent, electrodes etc., in a fenestration formed through a subject's otic capsule bone of the cochlea, particularly the promontory thereof.
Another object is to facilitate removing a therapeutic appliance, such as a microactuator or micropump for drug or therapeutic agent delivery device, electrodes etc., from a fenestration formed through a subject's otic capsule bone of the cochlea, particularly the promontory thereof.
Another object is to provide an easily implanted casing for securely attaching a therapeutic appliance such as a microactuator of an implantable hearing aid system to a fenestration formed through a subject's promontory.
Yet another object is to provide surgical burrs that permit safely fenestrating the lateral wall of the otic capsule bone adjacent to the scala tympani of the cochlea without damage to the membranous labyrinth or organ of corti and thus, without damage to hearing.
Briefly, in one aspect disclosed is a set of fenestration burrs that includes an initial fenestration burr and a sequence of fenestration polishing burrs. The set of fenestration burrs is adapted for use in conjunction with a microdrill for forming a cylindrically-shaped fenestration through a wall of a cochlea of a subject.
The initial fenestration burr includes an elongated shaft one end of which is adapted to be secured to the microdrill for rotating the initial fenestration burr while being used for forming the fenestration. A polishing burr is located along the shaft at a distal end of the shaft furthest from the end thereof that is adapted to be secured into the microdrill. The polishing burr has a cylindrically-shaped outer surface which carries at least one recessed, spiral-shaped flute. The initial fenestration burr also includes a washer-shaped initial burr collar that is:
Each of the fenestration polishing burrs in the sequence of fenestration polishing burrs includes an elongated shaft one end of which is adapted to be secured to the microdrill for rotating the fenestration polishing burr while being used for forming the fenestration. A polishing burr is located along the shaft at a distal end of the shaft furthest from the end thereof that is adapted to be secured into the microdrill. The polishing burr has a cylindrically-shaped outer surface which carries at least one recessed, spiral-shaped flute. Each polishing burr of the fenestration polishing burrs has a length in a direction parallel to the shaft which exceeds a corresponding length of the polishing burr of the initial fenestration burr. Each fenestration polishing burr also includes a washer-shaped polishing burr collar that is:
Configured in this way, the set of fenestration burrs are adapted for forming cylindrically-shaped fenestrations through walls of cochlea which exhibit uniform, repeatable diameters. Moreover, the spiral-shaped flutes on the polishing burr respectively of the initial fenestration burr and the sequence of fenestration polishing burrs keep cochlear bone dust out of a subject's inner ear while forming a fenestration.
In another aspect, disclosed is a casing adapted for implantation into a cylindrically-shaped fenestration that pierces a wall of a cochlea of a subject. The casing includes a hollow, cylindrically-shaped collar having a diameter which exceeds a diameter of the fenestration, and from a side of which extends a hollow, cylindrically-shaped sleeve. The hollow, cylindrically-shaped sleeve is adapted to be received into the fenestration, and to be fixed there by at least one prong which has an end that juts outward from the sleeve. Jutting out in this way the prong is adapted for engaging the otic capsule bone surrounding the fenestration to thereby lock the casing in the fenestration.
In yet another aspect disclosed is a therapeutic appliance, e.g. a microactuator or a micropump, adapted for insertion into a sleeve of a casing that is adapted for implantation into and firmly fixing in a cylindrically-shaped fenestration that pierces a wall of a cochlea of a subject. The implanted casing includes a flange extending from one end of the sleeve. The flange is pierced by at least a first L-shaped slot having an open end that is located furthest from a juncture between the flange and an end of the sleeve. A portion of the L-shaped first slot extends circumferentially around the flange. The therapeutic appliance includes a cylindrically-shaped barrel that is adapted for insertion into the sleeve of the casing. The cylindrically-shaped barrel extends outward from one side of a cylindrically-shaped cap that is adapted for insertion into the flange of the casing upon insertion of the barrel into the casing's sleeve. The cap has at least a first pin projecting outward therefrom which is adapted to be received into the circumferential portion of the first slot of the casing when the barrel is fully inserted into the casing's sleeve.
These and other features, objects and advantages will be understood or apparent to those of ordinary skill in the art from the following detailed description of the preferred embodiment as illustrated in the various drawing figures.
In accordance with the present disclosure,
As illustrated in
Referring now to
Other laser cut slits piercing the sleeve 74 preferably establish three spork-shaped (3) prongs 92 respectively located circumferentially about the sleeve 74 between each pair of slits 82. An end 94 of each prong 92 is preferably formed as a pair of tines 96 that are shaped to jut outward from the casing 72. Laser cut slits piercing the sleeve 74 between the slits 82 and the collar 76 establish three (3) more spork-shaped prongs 102 equally spaced around the circumference of the sleeve 74. Each prong 102 is located essentially collinear with one of the slits 82. An end 104 of each prong 102 is preferably formed as three (3) tines 106 that are shaped to jut outward from the casing 72. Configured in this way, the prongs 92, 102 provide the casing 72 with two sets of three (3) barbs with each set of barbs being arranged circumferentially about the sleeve 74. Upon inserting the casing 72 into a properly formed fenestration 36, the prongs 92, 102 engage the otic capsule bone 34 surrounding the fenestration 36 to lock the casing 72 therein.
As best illustrated in
Configured in this way, as indicated by an arrowed line 128 the sleeve 74 of the casing 72 is adapted to receive a cylindrically-shaped barrel 132 of a microactuator 134. An O-ring 136 encircles the barrel 132 at a juncture between the barrel 132 and a cylindrically-shaped cap 138 of the microactuator 134. The cap 138 is formed with a diameter that fits within the flange 116 of the casing 72. A pair of pins 142, only one of which is visible in
A subject's body usually completes hermetic sealing of the casing 72 and the microactuator 134 to the promontory 32. The endothelial lining of the inner ear and the mucosal lining of the inner ear will migrate across a biocompatible membrane thus sealing the casing 72, microactuator 134 and the fenestration 36, similar to what occurs with the prosthesis following stapedectomy (i.e. fenestration of the stapes).
Other applications exist for the titanium casing 72 in addition to securing the microactuator 134 to the otic capsule bone 34. A micropump can be securely attached to the implanted casing 72 to deliver precisely measured doses of medication directly into the inner ear. For very small volume delivery, the drug delivery system may be shaped similar to the microactuator 134, and enclose a therapeutic agent reservoir right at the otic capsule bone 34. The micropump contains the necessary reservoir of medication when only tiny amounts (microliters) will be delivered from a pulsed piezoelectric mechanism at intervals.
If a larger reservoir of medication is required, a hermetically sealed container made from biocompatible materials (e.g., titanium) may be implanted in the mastoid cavity or subcutaneously. For example, if the drug reservoir is located away from the otic capsule bone 34, a capillary may connect the reservoir to a plug secured in the casing 72 similar to the disclosure of the U.S. patent application. The U.S. patent application is hereby incorporated by reference as though fully set forth here. Accordingly, such a reservoir is connected to an implanted micropump by hollow tubing extending from the mastoid cavity through the facial recess to the dispensing plug located in the casing 72 implanted into the otic capsule bone 34. The micropump is also connected to a programmable signal processor and battery implanted either in the mastoid cavity or subcutaneously with leads extending through the facial recess or antrum. The micropump would be activated by telemetry either for single dose or by signal processor programmed by telemetry to adjust the dosage and frequency of medication delivery to the inner ear. The subcutaneous reservoir may be periodically refilled by transcutaneous injection utilizing sterile techniques.
As disclosed in the U.S. patent application, an approach similar to that described for drug delivery also permits introducing different types of electrodes into the scala tympani 44 which may prove helpful in treating tinnitus, or some forms of nerve deafness.
Fenestrating the promontory 32 or other area of the otic capsule bone 34 may be safely performed with set of guarded burrs such as those disclosed in the U.S. patent application. However, fenestration burrs of the type illustrated respectively in
The polishing burr 152 also preferably includes a pair of flutes 166 recessed into diametrically opposite sides thereof. Each of the flutes 166 spiral about the outer surface of the polishing burr 152 beginning at the end face 156 and extending through an aperture 168 that pierces the collar 162. While drilling into the promontory 32, the flutes 166 extract bone dust from the fenestration 36. Keeping bone dust out of the inner ear prevents foreign body reaction. Also, extracting bone dust consistently produces fenestrations 36 having a uniform, repeatable diameter.
1. omit the cutting tip 158; and
2. have a longer polishing burr 152′.
Preferably, forming the fenestration 36 employs successive fenestration polishing burrs 180 which in one instance respectively have polishing burrs 152′ which are 1.5 mm, 1.75 mm, 2.0 mm and 2.25 mm long. In a presently more preferred instance the polishing burrs 152′ of successive fenestration polishing burrs 180 are 1.40 mm, 1.80 mm and 2.20 mm long.
A fenestration 36 formed with the initial fenestration burr 150 and the set of fenestration polishing burrs 180 described herein has a nominal diameter of 1.40 mm. To permit the prongs 92, 102 engage the promontory 32 of the otic capsule bone 34 surrounding the fenestration 36 to lock the casing 72 therein, the sleeve 74 preferably has a diameter of 1.30 mm with a wall thickness of 0.05 mm. The rim 112 of the collar 76 is also preferably formed with a wall thickness of 0.05 mm. Thus the rim 112 fits snugly into and seals with the 1.40 mm diameter fenestration 36. To ensure that the O-ring 136 seals between the collar 76 and the microactuator 134, the collar 76 is preferably welded to the sleeve 74 with a 0.1 mm relief 192 illustrated in
In general, many if not all of the techniques described above can be used when attaching a microactuator, a micropump, capillary, electrode, or combination microactuator/electrode into a fenestration 36 that pierces the wall of the otic capsule bone 34.
Using such techniques, it is anticipated that conditions such as vertigo, tinnitus, sudden sensorineural hearing loss, endolymphatic hydrops (Meniere's disease), autoimmune inner ear disease, and serous or viral labyrinthitis could be improved by delivering carefully measured doses of a variety of medications (steroids, vasodilators, immune suppressants, anticoagulants, antibiotics, antiviral agents, plasma expanders, antioxidants, etc.) directly into the inner ear. Research has recently discovered that hair cells in the otic capsule bone 34 and vestibular labyrinth of some vertebrates have the ability to regenerate. Perhaps one day it may be possible to deliver a substance (e.g., neurohormone, hair cell DNA actuator) into the inner ear that will stimulate the regrowth of hair cells in the otic capsule bone 34 in patients with sensorineural hearing loss or repair damaged vestibular hair cells.
Another use for the casing 72 disclosed herein is introducing an electrode into the inner ear and securely attaching it to the wall of the cochlea. Application of low dose electrical current can depolarize hair cells or neurons and may someday be used to relieve tinnitus or vertigo triggered by irritable peripheral hair cells or afferent neurons. Some forms of sensorineural hearing loss result from atrophy of the stria vascularis 54 and the associated reduction in the resting cochlear potential across hair cells. A tiny electrode inserted in scala tympani 44 may be able to restore this bioelectric potential and improve this form of nerve deafness.
In each of the applications described above, attaching the microactuator, micropump, or electrode to the titanium casing 72 lining the fenestration 36 enables the surgeon to remove the device with minimal risk of damage to the inner ear. A new device can be inserted to replace an existing one, or an existing device may replaced by a “plug” if the device is no longer needed.
Although the casing 72, sleeve 74, initial fenestration burr 150 and fenestration polishing burrs 180 are described herein in terms of their presently preferred embodiments, it is to be understood that such disclosure is purely illustrative and is not to be interpreted as limiting. Thus, for example while the casing 72 is described as preferably being made from titanium, it may be fabricated from any biocompatible material which exhibits suitable characteristics that permit the prongs 92, 102 to engage the otic capsule bone 34 surrounding the fenestration 36 to lock the casing 72 therein. Similarly, while the casing 72 has been described as being assembled by welding the collar 76 to the sleeve 74, it may also be machined from a single piece of material. Correspondingly, more or fewer than three slits 82 may pierce the sleeve 74 in orientations other than equally spaced, and more or fewer than six (6) prongs 92, 102 may be formed on the sleeve 74 jutting outward therefrom in locations other than those depicted in
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2006/010673 | 5/22/2006 | WO | 00 | 9/11/2007 |
Number | Date | Country | |
---|---|---|---|
60664570 | Mar 2005 | US |